A DIAGNOSTIC ALGORITHM FOR HELICOBACTER PYLORI DETECTION AND IDENTIFICATION IN GASTRIC MUCOSAL BIOPSIES



Cite item

Full Text

Abstract

Helicobacter pylori is a major etiological agent in gastritis, peptic ulcer disease, gastric adenocarcinoma, and MALT lymphoma. While gastric mucosal biopsies are the primary material for invasive diagnosis, a comprehensive diagnostic approach is needed. This study presents a diagnostic algorithm that facilitates not only H. pylori detection and identification but also, when necessary, the subsequent analysis of isolated microbial strains, e.g., virulence gene determinants or antibiotic resistance mutations.

Having applied this algorithm from 2013 to 2024, we examined gastric biopsies from 610 patients (57% female, 43% male) aged 19–73 years with various gastrointestinal pathologies using culture and molecular methods. In our study, H. pylori detection rate by PCR vs. culture examination (48.20 % vs. 32.3%, respectively) in gastric biopsies was significantly higher. In gastric cancer, H. pylori DNA detection rate was minimal and amounted to 35.7%, which correlated with the lowest culture-based isolation rate (9.5%).

Since vacA virulence gene is presented in all H. pylori strains, it was used as a marker for H. pylori detection in our study. Thus, the vacA gene was detected in 48.0% (258/537) biopsy samples. The cagA gene is not presented in all H. pylori strains and considered to be a high virulence marker. In addition, it was found out that the cagA gene was present in 47.3% H. pylori-positive cases. Notably, the proportion of cagA-positive isolates turned out to be minimal in chronic gastritis – 39.4%, in contrast to its level in peptic ulcer and gastric cancer comprising 77.3% (p<0.001) and 72.7% (p=0.029), respectively.

In conclusion, the proposed diagnostic algorithm is applicable in microbiological practice for diagnosis, epidemiological monitoring, and research in H. pylori infections.

About the authors

Alena V. Svarval

St. Petersburg Pasteur Institute, St. Petersburg, Russia

Email: alenasvar@rambler.ru
ORCID iD: 0000-0001-9340-4132

к.м.н., старший научный сотрудник, зав. лабораторией идентификации патогенов

Россия, 14, Mira str., St. Petersburg, 197101

Daria A. Starkova

St. Petersburg Pasteur Institute, St. Petersburg, Russia

Email: dariastarkova13@gmail.com
ORCID iD: 0000-0003-3199-8689

PhD (Biology), Senior Researcher of the Pathogens Identification Laboratory, Researcher of the Laboratory of Molecular Epidemiology and Evolutionary Genetics

Россия, 197101, St. Petersburg, Mira str., 14

Lidia A. Kaftyreva

St. Petersburg Pasteur Institute, St. Petersburg, Russia;
North-Western State Medical University named after I.I. Mechnikov, Petersburg, Russia

Author for correspondence.
Email: kaflidia@mail.ru
ORCID iD: 0000-0003-0989-1404
SPIN-code: 6721-7873

DSc (Medicine), Leading Researcher, Typhoid Epidemiology Research Group; Professor, Department of Medical Microbiology

Россия, St. Petersburg; St. Petersburg

References

  1. Бордин Д. С. Ошибки диагностики и лечения инфекции Helicobacter pylori: в преддверии новых согласительных документов. Экспериментальная и клиническая гастроэнтерология, 2021, Т. 193(9), с. 5–14. Bordin D. S. Errors in the diagnosis and treatment of Helicobacter pylori infection: on the eve of new conciliation documents. Experimental and Clinical Gastroenterology, 2021, vol. 193(9), pp. 5-14. [doi: 10.31146/1682-8658-ecg-193-9-5-14]
  2. Жебрун А.Б., Сварваль А.В., Гончарова Л.Б., Ферман Р.С. Хеликобактеры. Клиническая лабораторная диагностика: национальное руководство. М.: ГЭОТАР-Медиа, 2012. Т. II. С. 394 – 406. Zhebrun A.B., Svarval A.V., Goncharova L.B., Ferman R.S. Helicobacters. Clinical laboratory diagnostics: national guidelines. M.: GEOTAR-Media, 2012. T. II. P. 394 – 406. [https://www.geotar.ru/lots/Q0119537.html]
  3. Ansari S., Yamaoka Y. Helicobacter pylori Infection, Its Laboratory Diagnosis, and
  4. Antimicrobial Resistance: a Perspective of Clinical Relevance. American Society for Microbiology Clinical Microbiology Reviews, 2022, Vol. 35, Iss. 3. [doi: 10.1128/cmr.00258-21]
  5. Graham D. Y., Liou J. M. Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship. Clin. Gastroenterol. Hepatol, 2021, Vol. 20, pp. 973–983. 1. [doi: 10.1016/j.cgh.2021.03.026].
  6. Graham D.Y., Moss S.F. Antimicrobial susceptibility testing for Helicobacter pylori is now widely available: The Who’s, When’s, and How’s. Am J Gastroenterol, 2022, Vol. 117, pp. 524-528. [doi: 10.14309/ajg.0000000000001659]
  7. Hooi J. K. Y., Lai W.Y., Ng W.K., Suen M., Underwood F., Tanyingoh D., Malfertheiner P., Gracham D., Wong V., Wu J., Chan F., Sung J., Kaplan G., Ng S.C. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology, 2017, Vol. 153, pp. 420–429. [doi: 10.1053/j.gastro.2017.04.022]
  8. Liou J.M., MalfertheinerP., Lee Y.C., Sheu B.S., Sugano K., Cheng H.C., Yeoh K.G., Hsu P.I., Goh K.L., Mahachai V., Gotoda T., Chang W.L., Chen M.J., Chiang T.H., Chen C.C., Wu C.Y., Leow A.H., Wu J.Y., Wu D.C., Hong T.C., Lu H., Yamaoka Y., Megraud F., Chan F.K.L., Sung J.J., Lin J.T., Graham D.Y., Wu M.S., El-Omar E.M.; Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut, 2020, Vol. 69, pp. 2093-2112. [doi: 10.1136/gutjnl-2020-322368].
  9. Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou J.M., Schulz C., Gasbarrini A., Hunt R.H., Leja M., O'Morain C., Rugge M., Suerbaum S., Tilg H., Sugano K., El-Omar E.M. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut, 2022, Vol.71, pp. 1724–1762. [doi: 10.1136/gutjnl-2022-327745]
  10. Malfertheiner P., Camargo M. C., El-Omar E., Liou J.-M., Peek R., Schulz C., Smith S. I., Suerbaum S. Helicobacter pylori infection. Nature Reviews Disease Primers, 2023, Vol. 9: 19. [doi: 10.1038/s41572-023-00431-8]
  11. Rugge M, Savarino E, Sbaraglia M, Bricca L, Malfertheiner P. Gastritis: The clinico-pathological spectrum. Dig Liver Dis., 2021, Vol. 53, pp. 1237-1246. [doi: 10.1016/j.dld.2021.03.007].
  12. Sabbagh P., Mohammadnia-Afrouzi M., Javanian M., Babazadeh A., Koppolu V., Vasigala V.K.R., Nouri H.R., Ebrahimpour S. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. European Journal of Clinical Microbiology & Infectious Diseases, 2019, Vol. 38, pp. 55–66 [https://doi.org/10.1007/s10096-018-3414-4]
  13. Thrift A. P., Wenker T. N., El-Serag H. B. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention / Nature Reviews Clinical Oncology. 2023. – V. 20. – Р.338–349. [https://doi.org/10.1038/s41571-023-00747-0[]
  14. Warren J. R., Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1983, Vol. 1, pp. 1273–1275. [https://pubmed.ncbi.nlm.nih.gov/6134060/]

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Svarval A.V., Starkova D.A., Kaftyreva L.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies